Abstract
Several types of collaboration are being pursued to identify, validate and apply new biomarkers. Here, we highlight examples of such initiatives and discuss the challenges, approaches to address these challenges and key factors for success.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wholley, D. The Biomarkers Consortium. Nat. Rev. Drug. Discov. 13, 791–792 (2014).
Stephenson, D. & Sauer, J. M. The Predictive Safety Testing Consortium and the Coalition Against Major Diseases. Nat. Rev. Drug. Discov. 13, 793–794 (2014).
Lessl, M. et al. Crowd sourcing in drug discovery. Nat. Rev. Drug. Discov. 10, 241–242 (2011).
Küffner, R. et al. Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression. Nat. Biotech. 33, 51–57 (2015).
Dorsch, H. et al. Grants4Targets — an open innovation initiative to foster drug discovery collaborations between academia and the pharmaceutical industry. Nat. Rev. Drug. Discov. 14, 74–76 (2015).
Acknowledgements
The authors would like to thank T. Schlange, M. Lessl, H. Dorsch (all at Bayer, Germany), and H.-D. Volk (at the Berlin-Brandenburg Center for Regenerative Therapies, Charité, Berlin, Germany) for helpful discussions, and P. Carrigan for critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
L.L. and P.R. have no conflict of interest to declare. K.A., A.B. and M.G. are employees and shareholders of Bayer.
Supplementary information
Supplementary information S1 (table)
Examples of biomarker consortia supported by public funding in Europe and the United States (PDF 92 kb)
Rights and permissions
About this article
Cite this article
Asadullah, K., Busch, A., Gottwald, M. et al. Industry–academia collaborations for biomarkers. Nat Rev Drug Discov 14, 805–806 (2015). https://doi.org/10.1038/nrd4727
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4727
This article is cited by
-
Bridging the translational innovation gap through good biomarker practice
Nature Reviews Drug Discovery (2017)
